Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 581 (ZNF581) is a human protein encoded by the ZNF581 gene and belongs to the zinc finger protein family, a group characterized by their zinc finger motifs that typically enable binding to DNA, RNA, or proteins[1][2][3][4]. ZNF581 is predicted to enable DNA-binding transcription factor activity, specifically participating in sequence-specific binding of cis-regulatory regions that control transcription by RNA polymerase II[1][3][4]. The protein is localized to the nucleus and is considered to be involved in the regulation of gene expression. No direct evidence indicates that ZNF581 is a therapeutic target, natural disease biomarker, or that it interacts with approved drugs[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 581 (ZNF581).